ketamine has been researched along with Anterior Horn Cell Disease in 1 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gold, ND | 1 |
| Mallard, AJ | 1 |
| Hermann, JC | 1 |
| Zeifman, RJ | 1 |
| Pagni, BA | 1 |
| Bogenschutz, MP | 1 |
| Ross, S | 1 |
1 review available for ketamine and Anterior Horn Cell Disease
| Article | Year |
|---|---|
Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Hallucinogens; Humans; Ketamine; Motor Neuron Disease; Neurodegenerat | 2023 |